APO Research
Talk to an analyst

APO RESEARCH · REPORT

Combined Hormonal Contraceptive

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Combined Hormonal Contraceptive Industry Growth and Trends Forecast to 2032

22 December 202596 pages

Choose your research edition.

Industry ResearchCombined Hormonal Contraceptive Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Combined Hormonal Contraceptive Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Combined Hormonal Contraceptive Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Combined Hormonal Contraceptive Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Combined Hormonal Contraceptive Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Combined Hormonal Contraceptive market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Combined Hormonal Contraceptive is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Combined Hormonal Contraceptive is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Combined Hormonal Contraceptive is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Combined Hormonal Contraceptive include Teva Pharmaceutical Industries, Johnson & Johnson, Novartis International, Pfizer, GlaxoSmithKline, Bayer HealthCare Pharmaceuticals, Watson Pharma, Cipla and Actavis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Combined Hormonal Contraceptive market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Combined Hormonal Contraceptive market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Combined Hormonal Contraceptive market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Combined Hormonal Contraceptive.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Combined Hormonal Contraceptive market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Combined Hormonal Contraceptive Market by Company

Teva Pharmaceutical Industries

Johnson & Johnson

Novartis International

Pfizer

GlaxoSmithKline

Bayer HealthCare Pharmaceuticals

Watson Pharma

Cipla

Actavis

Combined Hormonal Contraceptive Segment by Type

Ring

Patch

Pills

Combined Hormonal Contraceptive Segment by Application

E-commerce

Retail Pharmacies

Hospital Pharmacies

Others

Combined Hormonal Contraceptive Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Combined Hormonal Contraceptive market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Combined Hormonal Contraceptive and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Combined Hormonal Contraceptive.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Combined Hormonal Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Combined Hormonal Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ring Table 2. Major Company of Patch Table 3. Major Company of Pills Table 4. Global Combined Hormonal Contraceptive Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Combined Hormonal Contraceptive Sales by Type (2021-2026) & (k units) Table 6. Global Combined Hormonal Contraceptive Sales Market Share in Volume by Type (2021-2026) Table 7. Global Combined Hormonal Contraceptive Sales by Type (2021-2026) & (US$ Million) Table 8. Global Combined Hormonal Contraceptive Sales Market Share in Value by Type (2021-2026) Table 9. Global Combined Hormonal Contraceptive Price by Type (2021-2026) & (US$/unit) Table 10. Global Combined Hormonal Contraceptive Sales by Type (2027-2032) & (k units) Table 11. Global Combined Hormonal Contraceptive Sales Market Share in Volume by Type (2027-2032) Table 12. Global Combined Hormonal Contraceptive Sales by Type (2027-2032) & (US$ Million) Table 13. Global Combined Hormonal Contraceptive Sales Market Share in Value by Type (2027-2032) Table 14. Global Combined Hormonal Contraceptive Price by Type (2027-2032) & (US$/unit) Table 15. North America Combined Hormonal Contraceptive Sales by Type (2021-2026) & (k units) Table 16. North America Combined Hormonal Contraceptive Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Combined Hormonal Contraceptive Sales by Type (2021-2026) & (k units) Table 18. Europe Combined Hormonal Contraceptive Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Combined Hormonal Contraceptive Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Combined Hormonal Contraceptive Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Combined Hormonal Contraceptive Sales by Type (2021-2026) & (k units) Table 22. Latin America Combined Hormonal Contraceptive Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Combined Hormonal Contraceptive Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Combined Hormonal Contraceptive Sales by Type (2021-2026) & (US$ Million) Table 25. Combined Hormonal Contraceptive Industry Trends Table 26. Combined Hormonal Contraceptive Industry Drivers Table 27. Combined Hormonal Contraceptive Industry Opportunities and Challenges Table 28. Combined Hormonal Contraceptive Industry Restraints Table 29. Global Combined Hormonal Contraceptive Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Combined Hormonal Contraceptive Revenue Market Share by Company (2021-2026) Table 31. Global Combined Hormonal Contraceptive Sales by Company (2021-2026) & (k units) Table 32. Global Combined Hormonal Contraceptive Sales Share by Company (2021-2026) Table 33. Global Combined Hormonal Contraceptive Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Combined Hormonal Contraceptive Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Combined Hormonal Contraceptive Major Company Production Sites and Headquarters Table 36. Global Combined Hormonal Contraceptive Company, Product Type & Application Table 37. Global Combined Hormonal Contraceptive Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Combined Hormonal Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Combined Hormonal Contraceptive Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Combined Hormonal Contraceptive Sales by Region (2021-2026) & (k units) Table 42. Global Combined Hormonal Contraceptive Sales Market Share in Volume by Region (2021-2026) Table 43. Global Combined Hormonal Contraceptive Sales by Region (2021-2026) & (US$ Million) Table 44. Global Combined Hormonal Contraceptive Sales Market Share in Value by Region (2021-2026) Table 45. Global Combined Hormonal Contraceptive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Combined Hormonal Contraceptive Sales by Region (2027-2032) & (k units) Table 47. Global Combined Hormonal Contraceptive Sales Market Share in Volume by Region (2027-2032) Table 48. Global Combined Hormonal Contraceptive Sales by Region (2027-2032) & (US$ Million) Table 49. Global Combined Hormonal Contraceptive Sales Market Share in Value by Region (2027-2032) Table 50. Global Combined Hormonal Contraceptive Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Combined Hormonal Contraceptive Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Combined Hormonal Contraceptive Sales by Application (2021-2026) & (k units) Table 53. Global Combined Hormonal Contraceptive Sales Market Share in Volume by Application (2021-2026) Table 54. Global Combined Hormonal Contraceptive Sales by Application (2021-2026) & (US$ Million) Table 55. Global Combined Hormonal Contraceptive Sales Market Share in Value by Application (2021-2026) Table 56. Global Combined Hormonal Contraceptive Price by Application (2021-2026) & (US$/unit) Table 57. Global Combined Hormonal Contraceptive Sales by Application (2027-2032) & (k units) Table 58. Global Combined Hormonal Contraceptive Sales Market Share in Volume by Application (2027-2032) Table 59. Global Combined Hormonal Contraceptive Sales by Application (2027-2032) & (US$ Million) Table 60. Global Combined Hormonal Contraceptive Sales Market Share in Value by Application (2027-2032) Table 61. Global Combined Hormonal Contraceptive Price by Application (2027-2032) & (US$/unit) Table 62. North America Combined Hormonal Contraceptive Sales by Application (2021-2026) & (k units) Table 63. North America Combined Hormonal Contraceptive Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Combined Hormonal Contraceptive Sales by Application (2021-2026) & (k units) Table 65. Europe Combined Hormonal Contraceptive Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Combined Hormonal Contraceptive Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Combined Hormonal Contraceptive Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Combined Hormonal Contraceptive Sales by Application (2021-2026) & (k units) Table 69. Latin America Combined Hormonal Contraceptive Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Combined Hormonal Contraceptive Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Combined Hormonal Contraceptive Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Pharmaceutical Industries Company Information Table 73. Teva Pharmaceutical Industries Business Overview Table 74. Teva Pharmaceutical Industries Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Teva Pharmaceutical Industries Combined Hormonal Contraceptive Product Portfolio Table 76. Teva Pharmaceutical Industries Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Combined Hormonal Contraceptive Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Novartis International Company Information Table 83. Novartis International Business Overview Table 84. Novartis International Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Novartis International Combined Hormonal Contraceptive Product Portfolio Table 86. Novartis International Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Pfizer Combined Hormonal Contraceptive Product Portfolio Table 91. Pfizer Recent Development Table 92. GlaxoSmithKline Company Information Table 93. GlaxoSmithKline Business Overview Table 94. GlaxoSmithKline Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. GlaxoSmithKline Combined Hormonal Contraceptive Product Portfolio Table 96. GlaxoSmithKline Recent Development Table 97. Bayer HealthCare Pharmaceuticals Company Information Table 98. Bayer HealthCare Pharmaceuticals Business Overview Table 99. Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Product Portfolio Table 101. Bayer HealthCare Pharmaceuticals Recent Development Table 102. Watson Pharma Company Information Table 103. Watson Pharma Business Overview Table 104. Watson Pharma Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Watson Pharma Combined Hormonal Contraceptive Product Portfolio Table 106. Watson Pharma Recent Development Table 107. Cipla Company Information Table 108. Cipla Business Overview Table 109. Cipla Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Cipla Combined Hormonal Contraceptive Product Portfolio Table 111. Cipla Recent Development Table 112. Actavis Company Information Table 113. Actavis Business Overview Table 114. Actavis Combined Hormonal Contraceptive Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Actavis Combined Hormonal Contraceptive Product Portfolio Table 116. Actavis Recent Development Table 117. North America Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 118. North America Combined Hormonal Contraceptive Sales by Country (2021-2026) & (k units) Table 119. North America Combined Hormonal Contraceptive Sales Market Share by Country (2021-2026) Table 120. North America Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032) & (k units) Table 121. North America Combined Hormonal Contraceptive Sales Market Share Forecast by Country (2027-2032) Table 122. North America Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Combined Hormonal Contraceptive Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Combined Hormonal Contraceptive Market Share by Country (2021-2026) Table 125. North America Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Combined Hormonal Contraceptive Market Share Forecast by Country (2027-2032) Table 127. Europe Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. Europe Combined Hormonal Contraceptive Sales by Country (2021-2026) & (k units) Table 129. Europe Combined Hormonal Contraceptive Sales Market Share by Country (2021-2026) Table 130. Europe Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032) & (k units) Table 131. Europe Combined Hormonal Contraceptive Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Combined Hormonal Contraceptive Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Combined Hormonal Contraceptive Market Share by Country (2021-2026) Table 135. Europe Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Combined Hormonal Contraceptive Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Combined Hormonal Contraceptive Sales by Country (2021-2026) & (k units) Table 139. Asia-Pacific Combined Hormonal Contraceptive Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032) & (k units) Table 141. Asia-Pacific Combined Hormonal Contraceptive Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Combined Hormonal Contraceptive Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Combined Hormonal Contraceptive Market Share by Country (2021-2026) Table 145. Asia-Pacific Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Combined Hormonal Contraceptive Market Share Forecast by Country (2027-2032) Table 147. Latin America Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Latin America Combined Hormonal Contraceptive Sales by Country (2021-2026) & (k units) Table 149. Latin America Combined Hormonal Contraceptive Sales Market Share by Country (2021-2026) Table 150. Latin America Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032) & (k units) Table 151. Latin America Combined Hormonal Contraceptive Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Combined Hormonal Contraceptive Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Combined Hormonal Contraceptive Market Share by Country (2021-2026) Table 155. Latin America Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Combined Hormonal Contraceptive Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Combined Hormonal Contraceptive Sales by Country (2021-2026) & (k units) Table 159. Middle East and Africa Combined Hormonal Contraceptive Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032) & (k units) Table 161. Middle East and Africa Combined Hormonal Contraceptive Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Combined Hormonal Contraceptive Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Combined Hormonal Contraceptive Market Share by Country (2021-2026) Table 165. Middle East and Africa Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Combined Hormonal Contraceptive Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Combined Hormonal Contraceptive Distributors List Table 170. Combined Hormonal Contraceptive Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Combined Hormonal Contraceptive Image Figure 2. Global Combined Hormonal Contraceptive Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Combined Hormonal Contraceptive Market Size (2021-2032) & (US$ Million) Figure 4. Global Combined Hormonal Contraceptive Sales (2021-2032) & (k units) Figure 5. Ring Image Figure 6. Global Ring Sales YoY Growth (2021-2032) & (k units) Figure 7. Patch Image Figure 8. Global Patch Sales YoY Growth (2021-2032) & (k units) Figure 9. Pills Image Figure 10. Global Pills Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Combined Hormonal Contraceptive Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Combined Hormonal Contraceptive Market Share by Type 2025 VS 2032 Figure 13. North America Combined Hormonal Contraceptive Sales Market Share in Volume by Type in 2025 Figure 14. North America Combined Hormonal Contraceptive Sales Market Share in Value by Type in 2025 Figure 15. Europe Combined Hormonal Contraceptive Sales Market Share in Volume by Type in 2025 Figure 16. Europe Combined Hormonal Contraceptive Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Combined Hormonal Contraceptive Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Combined Hormonal Contraceptive Sales Market Share in Value by Type in 2025 Figure 19. Latin America Combined Hormonal Contraceptive Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Combined Hormonal Contraceptive Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Combined Hormonal Contraceptive Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Combined Hormonal Contraceptive Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Combined Hormonal Contraceptive Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. E-commerce Image Figure 26. Global E-commerce Sales YoY Growth (2021-2032) & (k units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospital Pharmacies Image Figure 30. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Combined Hormonal Contraceptive Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Combined Hormonal Contraceptive Market Share by Application 2025 VS 2032 Figure 35. North America Combined Hormonal Contraceptive Sales Market Share in Volume by Application in 2025 Figure 36. North America Combined Hormonal Contraceptive Sales Market Share in Value by Application in 2025 Figure 37. Europe Combined Hormonal Contraceptive Sales Market Share in Volume by Application in 2025 Figure 38. Europe Combined Hormonal Contraceptive Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Combined Hormonal Contraceptive Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Combined Hormonal Contraceptive Sales Market Share in Value by Application in 2025 Figure 41. Latin America Combined Hormonal Contraceptive Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Combined Hormonal Contraceptive Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Combined Hormonal Contraceptive Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Combined Hormonal Contraceptive Sales Market Share in Value by Application in 2025 Figure 45. North America Combined Hormonal Contraceptive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Combined Hormonal Contraceptive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Combined Hormonal Contraceptive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Combined Hormonal Contraceptive Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Combined Hormonal Contraceptive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Combined Hormonal Contraceptive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Combined Hormonal Contraceptive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Combined Hormonal Contraceptive Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Combined Hormonal Contraceptive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Combined Hormonal Contraceptive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Combined Hormonal Contraceptive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Combined Hormonal Contraceptive Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Combined Hormonal Contraceptive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Combined Hormonal Contraceptive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Combined Hormonal Contraceptive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Combined Hormonal Contraceptive Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Combined Hormonal Contraceptive Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Combined Hormonal Contraceptive Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Combined Hormonal Contraceptive Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Combined Hormonal Contraceptive Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Combined Hormonal Contraceptive Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Combined Hormonal Contraceptive Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ring
  • Patch
  • Pills
Applications
  • E-commerce
  • Retail Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Teva Pharmaceutical Industries
  • Johnson & Johnson
  • Novartis International
  • Pfizer
  • GlaxoSmithKline
  • Bayer HealthCare Pharmaceuticals
  • Watson Pharma
  • Cipla
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Combined Hormonal Contraceptive Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Combined Hormonal Contraceptive Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Combined Hormonal Contraceptive Market by Type
  6. 1.3.1 Ring
  7. 1.3.2 Patch
  8. 1.3.3 Pills
  9. 1.4 Global Combined Hormonal Contraceptive Market Size by Type
  10. 1.4.1 Global Combined Hormonal Contraceptive Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Combined Hormonal Contraceptive Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Combined Hormonal Contraceptive Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Combined Hormonal Contraceptive Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Combined Hormonal Contraceptive Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Combined Hormonal Contraceptive Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Combined Hormonal Contraceptive Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Combined Hormonal Contraceptive Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Combined Hormonal Contraceptive Industry Trends
  2. 2.2 Combined Hormonal Contraceptive Industry Drivers
  3. 2.3 Combined Hormonal Contraceptive Industry Opportunities and Challenges
  4. 2.4 Combined Hormonal Contraceptive Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Combined Hormonal Contraceptive Revenue (2021-2026)
  2. 3.2 Global Top Players by Combined Hormonal Contraceptive Sales (2021-2026)
  3. 3.3 Global Top Players by Combined Hormonal Contraceptive Price (2021-2026)
  4. 3.4 Global Combined Hormonal Contraceptive Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Combined Hormonal Contraceptive Major Company Production Sites & Headquarters
  6. 3.6 Global Combined Hormonal Contraceptive Company, Product Type & Application
  7. 3.7 Global Combined Hormonal Contraceptive Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Combined Hormonal Contraceptive Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Combined Hormonal Contraceptive Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Combined Hormonal Contraceptive Tier 1, Tier 2, and Tier 3
4 Combined Hormonal Contraceptive Regional Status and Outlook
  1. 4.1 Global Combined Hormonal Contraceptive Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Combined Hormonal Contraceptive Historic Market Size by Region
  3. 4.2.1 Global Combined Hormonal Contraceptive Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Combined Hormonal Contraceptive Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Combined Hormonal Contraceptive Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Combined Hormonal Contraceptive Forecasted Market Size by Region
  7. 4.3.1 Global Combined Hormonal Contraceptive Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Combined Hormonal Contraceptive Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Combined Hormonal Contraceptive Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Combined Hormonal Contraceptive by Application
  1. 5.1 Combined Hormonal Contraceptive Market by Application
  2. 5.1.1 E-commerce
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Combined Hormonal Contraceptive Market Size by Application
  7. 5.2.1 Global Combined Hormonal Contraceptive Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Combined Hormonal Contraceptive Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Combined Hormonal Contraceptive Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Combined Hormonal Contraceptive Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Combined Hormonal Contraceptive Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Combined Hormonal Contraceptive Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Combined Hormonal Contraceptive Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Combined Hormonal Contraceptive Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries
  2. 6.1.1 Teva Pharmaceutical Industries Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Combined Hormonal Contraceptive Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 6.2 Johnson & Johnson
  8. 6.2.1 Johnson & Johnson Company Information
  9. 6.2.2 Johnson & Johnson Business Overview
  10. 6.2.3 Johnson & Johnson Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Combined Hormonal Contraceptive Product Portfolio
  12. 6.2.5 Johnson & Johnson Recent Developments
  13. 6.3 Novartis International
  14. 6.3.1 Novartis International Company Information
  15. 6.3.2 Novartis International Business Overview
  16. 6.3.3 Novartis International Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis International Combined Hormonal Contraceptive Product Portfolio
  18. 6.3.5 Novartis International Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Combined Hormonal Contraceptive Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GlaxoSmithKline
  26. 6.5.1 GlaxoSmithKline Company Information
  27. 6.5.2 GlaxoSmithKline Business Overview
  28. 6.5.3 GlaxoSmithKline Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 GlaxoSmithKline Combined Hormonal Contraceptive Product Portfolio
  30. 6.5.5 GlaxoSmithKline Recent Developments
  31. 6.6 Bayer HealthCare Pharmaceuticals
  32. 6.6.1 Bayer HealthCare Pharmaceuticals Company Information
  33. 6.6.2 Bayer HealthCare Pharmaceuticals Business Overview
  34. 6.6.3 Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer HealthCare Pharmaceuticals Combined Hormonal Contraceptive Product Portfolio
  36. 6.6.5 Bayer HealthCare Pharmaceuticals Recent Developments
  37. 6.7 Watson Pharma
  38. 6.7.1 Watson Pharma Company Information
  39. 6.7.2 Watson Pharma Business Overview
  40. 6.7.3 Watson Pharma Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Watson Pharma Combined Hormonal Contraceptive Product Portfolio
  42. 6.7.5 Watson Pharma Recent Developments
  43. 6.8 Cipla
  44. 6.8.1 Cipla Company Information
  45. 6.8.2 Cipla Business Overview
  46. 6.8.3 Cipla Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Cipla Combined Hormonal Contraceptive Product Portfolio
  48. 6.8.5 Cipla Recent Developments
  49. 6.9 Actavis
  50. 6.9.1 Actavis Company Information
  51. 6.9.2 Actavis Business Overview
  52. 6.9.3 Actavis Combined Hormonal Contraceptive Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Actavis Combined Hormonal Contraceptive Product Portfolio
  54. 6.9.5 Actavis Recent Developments
7 North America by Country
  1. 7.1 North America Combined Hormonal Contraceptive Sales by Country
  2. 7.1.1 North America Combined Hormonal Contraceptive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Combined Hormonal Contraceptive Sales by Country (2021-2026)
  4. 7.1.3 North America Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032)
  5. 7.2 North America Combined Hormonal Contraceptive Market Size by Country
  6. 7.2.1 North America Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Combined Hormonal Contraceptive Market Size by Country (2021-2026)
  8. 7.2.3 North America Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Combined Hormonal Contraceptive Sales by Country
  2. 8.1.1 Europe Combined Hormonal Contraceptive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Combined Hormonal Contraceptive Sales by Country (2021-2026)
  4. 8.1.3 Europe Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Combined Hormonal Contraceptive Market Size by Country
  6. 8.2.1 Europe Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Combined Hormonal Contraceptive Market Size by Country (2021-2026)
  8. 8.2.3 Europe Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Combined Hormonal Contraceptive Sales by Country
  2. 9.1.1 Asia-Pacific Combined Hormonal Contraceptive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Combined Hormonal Contraceptive Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Combined Hormonal Contraceptive Market Size by Country
  6. 9.2.1 Asia-Pacific Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Combined Hormonal Contraceptive Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Combined Hormonal Contraceptive Sales by Country
  2. 10.1.1 South America Combined Hormonal Contraceptive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Combined Hormonal Contraceptive Sales by Country (2021-2026)
  4. 10.1.3 South America Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032)
  5. 10.2 South America Combined Hormonal Contraceptive Market Size by Country
  6. 10.2.1 South America Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Combined Hormonal Contraceptive Market Size by Country (2021-2026)
  8. 10.2.3 South America Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Combined Hormonal Contraceptive Sales by Country
  2. 11.1.1 Middle East and Africa Combined Hormonal Contraceptive Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Combined Hormonal Contraceptive Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Combined Hormonal Contraceptive Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Combined Hormonal Contraceptive Market Size by Country
  6. 11.2.1 Middle East and Africa Combined Hormonal Contraceptive Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Combined Hormonal Contraceptive Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Combined Hormonal Contraceptive Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Combined Hormonal Contraceptive Value Chain Analysis
  2. 12.1.1 Combined Hormonal Contraceptive Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Combined Hormonal Contraceptive Production Mode & Process
  7. 12.2 Combined Hormonal Contraceptive Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Combined Hormonal Contraceptive Distributors
  10. 12.2.3 Combined Hormonal Contraceptive Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst